[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371413-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371413-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","performance-of-a-logistic-regression-model-using-paired-mirnas-to-stratify-abnormal-mammograms-for-benign-breast-lesions","Performance of a Logistic Regression Model Using Paired miRNAs to Stratify Abnormal Mammograms for Benign Breast Lesions","","Mammography reduces breast cancer mortality but generates false positives that trigger unnecessary biopsies or interval repeat imaging. This study addresses the need for accurate molecular classifiers that can identify low-risk women and avoid additional invasive or burdensome diagnostic procedures. miRNA profiling was performed on prospectively collected serum from 432 participants, with 265 selected for analysis, developing the EarlyGuard classifier using paired miRNAs and validating it on independent test cohorts.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/performance-of-a-logistic-regression-model-using-paired-mirnas-to-stratify-abnormal-mammograms-for-benign-breast-lesions/371413/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/performance-of-a-logistic-regression-model-using-paired-mirnas-to-stratify-abnormal-mammograms-for-benign-breast-lesions/371413.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is a new molecular classifier needed for abnormal mammograms?","Question",{"text":63,"@type":64},"Screening mammography can produce false positives, leading to biopsies or interval repeat mammography. An accurate molecular classifier could reduce unnecessary imaging and invasive diagnostics for low-risk women.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the EarlyGuard miRNA classifier developed?",{"text":68,"@type":64},"miRNA profiling was performed on serum specimens from participants with abnormal mammogram results. A logistic regression model using paired miRNAs was used to generate the EarlyGuard classifier.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic performance did the classifier achieve in training and test sets?",{"text":72,"@type":64},"In the training set (174 subjects), the classifier showed NPV 96.4% and sensitivity 91.2%. In the independent test set (91 subjects), NPV and sensitivity were estimated at 96.9% and 95.8%, respectively.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371413,1790232763,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nPerformance of a Logistic Regression Model Using Paired miRNAs to Stratify Abnormal Mammograms for Benign Breast Lesions  \nHideo Akiyama1  | Lora Barke2 | Therese B. Bevers3 | Suzanne J. Rose4  | Jennifer J. Hu5 | Kelly A. McAleese6 | Shellie S. Campos7 | Satoshi Kondou1 | Jun Atsumi8 | Thomas F. Soriano9  \n1Toray Industries, Inc. , Kamakura, Kanagawa, Japan | 2Invision Sally Jobe/Radiology Imaging Associates, Englewood, Colorado, USA | 3Division of OVP, Department of Clinical Cancer Prevention, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA | 4Department of Research and Discovery, Stamford Health, Breast Center, Stamford Health, Stamford, Connecticut, USA | 5Department of Public Health Science, University of Miami School of Medicine, Miami, Florida, USA | 6The Women's Imaging Center, Denver, Colorado, USA | 7John Muir Health, Walnut Creek and Concord, California, USA | 8Toray Industries, Inc., Tokyo, Japan | 9Diagnostic Oncology CRO, LLC, Oxford, Connecticut, USA  \nCorrespondence: Hideo Akiyama ([hideo.akiyama.v8@mail.toray](hideo.akiyama.v8@mail.toray))  \nReceived: 1 April 2024 | Revised: 8 January 2025 | Accepted: 6 February 2025  \nFunding: The authors received no specific funding for this work.  \nKeywords: abnormal mammogram | benign breast lesions | breast cancer | liquid biopsy | serum miRNA  \nABSTRACT  \nBackground: Mammography is effective in reducing breast cancer mortality, but it has false positive results that cause subsequent interventions such as biopsy or interval repeat mammography. Thus, there is a clinical unmet need for accurate molecular classifiers that can reduce unnecessary additional imaging and/or invasive diagnostic procedures for low-risk women.  \nMethod: We performed miRNA profiling on a prospectively collected serum specimen obtained from each of the 432 subjects who received an abnormal mammogram or imaging result and then selected 265 subjects for further analysis. The miRNA classifier, named EarlyGuard, was generated based on a novel logistic regression model using “paired miRNAs” where the two miRNAs of interest exhibit the same properties.  \nResults: The classifier developed using the training set of 174 subjects enrolled at seven investigative sites resulted in a negative predictive value (NPV) and a sensitivity of 96.4% and 91.2%, respectively. The classifier was validated using the test set consisting of 91 subjects enrolled at three investigative sites, two of which were not included in the training set. The resulting NPV and sensitivity were estimated similarly to be 96.9% and 95.8%, respectively.  \nConclusions: Our miRNA classifier has produced promising results that could be used in conjunction with mammography or other imaging procedures to reduce unnecessary invasive diagnostic procedures for women who are unlikely to have a suspicious or worse result on a subsequent diagnostic biopsy. Additional studies will be conducted in larger cohorts to determine if the sensitivity of the classifier will be improved.  \n1 | Introduction  \nMammography is considered the principal non-invasive imaging method of screening for breast cancer worldwide. It has  \nbeen shown to be effective in reducing breast cancer deaths in several randomized studies [1, 2] . However, screening mammography can result in false positives that cause subsequent interventions such as biopsy or interval repeat mammography.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2025; 14:e70767 1 of 16  \n[https://doi.org/10.1002/cam4.70767](https://doi.org/10.1002/cam4.70767)  \nIt is estimated that each year $2.8 billion is spent [in the U.S. as](in the U.S. as)[a result of","cbCaie7hhnBpE8v9","https://ap.wps.com/l/cbCaie7hhnBpE8v9","pdf",2329228,16,"English","# Abstract\n## Background\n## Method\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"Why is a new molecular classifier needed for abnormal mammograms?\",\"answer\":\"Screening mammography can produce false positives, leading to biopsies or interval repeat mammography. An accurate molecular classifier could reduce unnecessary imaging and invasive diagnostics for low-risk women.\"},{\"question\":\"How was the EarlyGuard miRNA classifier developed?\",\"answer\":\"miRNA profiling was performed on serum specimens from participants with abnormal mammogram results. A logistic regression model using paired miRNAs was used to generate the EarlyGuard classifier.\"},{\"question\":\"What diagnostic performance did the classifier achieve in training and test sets?\",\"answer\":\"In the training set (174 subjects), the classifier showed NPV 96.4% and sensitivity 91.2%. In the independent test set (91 subjects), NPV and sensitivity were estimated at 96.9% and 95.8%, respectively.\"}]","Performance of a Logistic Regression Model Using Paired miRNAs to Stratify Abnormal Mammograms for Benign Breast Lesions | PDF",1790192016,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e5b297a7a4d86ab517764cffa336c1f.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bfd6ef077cb8690088a3e9b6e73d5e4.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23df0810a8bf6624f7ef78609ce8b3c2.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eab6111024843da5b8918263f9ee9191.webp",980,1287]